+ Filter
Loading...
CD22 & saporin
Loading...Anti-CD22 & saporin Products
- Anti-Human CD22 Recombinant Antibody (TAB-183-F(E)) (TAB-183-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fv - disulfide stabilized
- Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG4, κ
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG1
- Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
- Human Anti-CD22 Recombinant Antibody (TAB-1722CL) (TAB-1722CL)
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
- Anti-Human CD22 Recombinant Antibody (RFB4) (TAB-1728CL)
-
- Application: IF, FC
- Human Anti-CD22 Recombinant Antibody (TAB-1717CL) (TAB-1717CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-1718CL) (TAB-1718CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-1719CL) (TAB-1719CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: ELISA
- Human Anti-CD22 Recombinant Antibody (TAB-1720CL) (TAB-1720CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: ELISA
- Human Anti-CD22 Recombinant Antibody (TAB-1721CL) (TAB-1721CL)
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
- Mouse Anti-Human CD22 Recombinant Antibody (TAB-003LC)
-
- Application: FC
- Human Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-1725CL-F(E)) (TAB-1725CL-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: Block, Cyt, ELISA, FuncS
- Anti-Human CD22 Recombinant Antibody (VM1000) (TAB-002LC)
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: FC, ELISA, SPR, FuncS
- Human Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-1724CL-F(E)) (TAB-1724CL-F(E))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) Fab
- Application: Inhib
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1715CL-F(E)) (TAB-1715CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1716CL-F(E)) (TAB-1716CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1717CL-F(E)) (TAB-1717CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1718CL-F(E)) (TAB-1718CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1719CL-F(E)) (TAB-1719CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1720CL-F(E)) (TAB-1720CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1721CL-F(E)) (TAB-1721CL-F(E))
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1722CL-F(E)) (TAB-1722CL-F(E))
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-001LC) (TAB-001LC)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric antibody (mouse/human)
- Application: ELISA
- Anti-Human CD22 Recombinant Antibody scFv Fragment (hLL2-Cys) (TAB-0197CL-S(P))
-
- Application: ELISA, In vivo
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1724CL-S(P)) (TAB-1724CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Inhib
- Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2) (TAB-0196CL-F(E))
-
- Application: ELISA, In vivo
- Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2-Cys) (TAB-0197CL-F(E))
-
- Application: ELISA, In vivo
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1715CL-S(P)) (TAB-1715CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1716CL-S(P)) (TAB-1716CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1717CL-S(P)) (TAB-1717CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1718CL-S(P)) (TAB-1718CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1719CL-S(P)) (TAB-1719CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1720CL-S(P)) (TAB-1720CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1721CL-S(P)) (TAB-1721CL-S(P))
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1722CL-S(P)) (TAB-1722CL-S(P))
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
- Anti-Human CD22 Recombinant Antibody scFv Fragment (hLL2) (TAB-0196CL-S(P))
-
- Application: ELISA, In vivo
- Human Anti-CD22 Recombinant Antibody (TAB-1729CL) (TAB-1729CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: IF, FC
- Human Anti-CD22 Recombinant Antibody (TAB-1715CL) (TAB-1715CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-1716CL) (TAB-1716CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-1724CL) (TAB-1724CL)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG1, κ
- Application: Inhib
- Human Anti-CD22 Recombinant Antibody (TAB-1725CL) (TAB-1725CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: Block, Cyt, ELISA, FuncS
-
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: IF, FC
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG1, κ
- Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
- Anti-CD22 immunotoxin RFB4 (IgG)-PE (AGTO-G077E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD22 immunotoxin RFB4 (IgG)-DT (AGTO-G077D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD22 immunotoxin RFB4 (scFv)-PE (AGTO-L048E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD22 immunotoxin RFB4 (scFv)-DT (AGTO-L048D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD22 immunotoxin RFB4 (IgG)-Gel (AGTO-G077G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD22 immunotoxin RFB4 (scFv)-Gel (AGTO-L048G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD22 immunotoxin RFB4 (IgG)-RTA (AGTO-G077R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD22 immunotoxin RFB4 (scFv)-RTA (AGTO-L048R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD22 immunotoxin RFB4 (IgG)-Sap (AGTO-G077S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD22 immunotoxin RFB4 (scFv)-Sap (AGTO-L048S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Recombinant Anti-Human CD22 Antibody Fab Fragment (MOB-1248z-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab
- Application: IP, RIA, FuncS
- Recombinant Anti-Human CD22 Antibody scFv Fragment (MOB-1248z-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: scFv
- Application: ELISA, WB, IF, FuncS
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab' - G2a - kappa
- Application: ELISA, FC, IP, FuncS, IF, Neut, WB
- Mouse Anti-CD22 Recombinant Antibody (TAB-1714CL) (TAB-1714CL)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, WB
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1723CL-S(P)) (TAB-1723CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Inhib
- Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-1714CL-F(E)) (TAB-1714CL-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, WB
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1714CL-S(P)) (TAB-1714CL-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, WB
- Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-1723CL-F(E)) (TAB-1723CL-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: Inhib
- Anti-Human CD22 Recombinant Antibody (TAB-004LC)
-
- Application: FC
- Anti-Human CD22 Recombinant Antibody Fab Fragment (RFB4) (TAB-1728CL-F(E))
-
- Application: IF, FC
-
- Targets: CD22 & saporin
- Type: Fab2
- Application: FuncS, Pretargeting system for immunotoxin delivery
- Anti-CD22 (clone 10F4v3)-BMPEO-DM1 ADC (ADC-211CL)
-
- Target: CD22
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-212CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-213CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (clone hLL2)-SN-38 ADC (ADC-124CL)
-
- Target: CD22
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
- Anti-CD22 (clone 5E8)-SMCC-DM1 ADC (ADC-214CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 7A2)-SMCC-DM1 ADC (ADC-215CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v1)-SMCC-DM1 ADC (ADC-216CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (RFB4)-mcc-DM1 ADC (ADC-028LCT)
-
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v2)-SMCC-DM1 ADC (ADC-217CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (10F4)-AcBut-Calicheamicin ADC (ADC-029LCT)
-
- Target: CD22
- Linker: AcBut
- Drug: Calicheamicin
- Anti-CD22 (clone 10F4v2)-MC-MMAF ADC (ADC-218CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22-CL2A-SN-38 ADC (ADC-030LCT)
-
- Target: CD22
- Linker: CL2A
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
- Anti-CD22 (clone 10F4v3)-SMCC-DM1 ADC (ADC-219CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22-CL2E-SN-38 ADC (ADC-031LCT)
-
- Target: CD22
- Linker: CL2E
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
- Anti-CD22 (clone G5/44)-AcBut-CalichDMH ADC (ADC-003LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
- Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-220CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22-mc-vc-PABc-NMS249 ADC (ADC-097LZY)
-
- Target: CD22
- Linker: mc-VC-PABc (maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: NMS249
- Anti-CD22-AcBut-CalichDMH ADC (ADC-006LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
- Anti-CD22-MC-MMAF ADC (ADC-032LCT)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (clone 10F4v3)-SPP-DM1 ADC (ADC-221CL)
-
- Target: CD22
- Linker: SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-222CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22-MCC-DM1 ADC (ADC-033LCT)
-
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (Pinatuzumab)-MC-VC-PABC-MMAE ADC (ADC-034LCT)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (clone hu10F4)-MCC-DM1 ADC (ADC-027LZY)
-
- Target: CD22
- Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD22 (Inotuzumab)-hydrazone-Calicheamicin ADC (ADC-036LCT)
-
- Target: CD22
- Linker: hydrazone
- Drug: Calicheamicin
- Anti-CD22 (clone 10F4)-SMCC-DM1 ADC (ADC-223CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (Inotuzumab)-DIBO-doxorubicin ADC (ADC-037LCT)
-
- Target: CD22
- Linker: DIBO (dibenzylcyclooctynol)
- Drug: doxorubicin
- Anti-CD22 (clone HB22.7)-saporin ADC (ADC-154LZY)
-
- Target: CD22
- Drug: saporin
- Anti-CD22-mc-vc-PABc-MMAE ADC (ADC-033LZY)
-
- Target: CD22
- Linker: mc-VC-PABc(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD22 (clone 10F4v3)-MCC-DM1 ADC (ADC-194LZY)
-
- Target: CD22
- Linker: MCC(Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD22 (clone RFB4)-SMCC-DM1 ADC (ADC-224CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v3)-mc-vc-PABC-MMAE ADC (ADC-195LZY)
-
- Target: CD22
- Linker: mc-VC-PABC(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD22 (clone RFB4)-MC-vc-PAB-MMAF ADC (ADC-225CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (clone RFB4)-MC-MMAF ADC (ADC-226CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
-
- Target: CD22
- Linker: acetyl butyrate linker
- Drug: calicheamicin
- Anti-CD22 (CR011)-vc-MMAE ADC (RG7593) (ADC-L028)
-
- Target: CD22
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
CD22 (CD22 Molecule) is a Protein Coding gene. Diseases associated with CD22 include refractory hematologic cancer and colon lymphoma. Among its related pathways are Immune System and Downstream signaling events of B Cell Receptor (BCR). GO annotations related to this gene include carbohydrate binding. An important paralog of this gene is VCAM1.
Saporin is a so-called ribosome inactivating protein (RIP), due to its N-glycosidase activity, from the seeds of Saponaria officinalis (common name: soapwort).Saporin depurinate the ribosomal RNA in a specific position; rendering the large subunit of ribosomes unable to bind the elongation factors. The consequent arrest of protein synthesis is responsible for the cytotoxicity.


